ctDNA levels or a recurrence of mutations after treatment can signal a relapse of the cancer before showing up on imaging or symptoms occurring, while clearance of ctDNA signals a positive trend towards recovery/remission [ 9 ].
← all excerpts
Beyond the Microscope: Integrating Liquid Biopsies into the Molecular Pathology Era of Endometrial Cancer.
1
—
—